193 related articles for article (PubMed ID: 32843541)
1. An allosteric site on MKP5 reveals a strategy for small-molecule inhibition.
Gannam ZTK; Min K; Shillingford SR; Zhang L; Herrington J; Abriola L; Gareiss PC; Pantouris G; Tzouvelekis A; Kaminski N; Zhang X; Yu J; Jamali H; Ellman JA; Lolis E; Anderson KS; Bennett AM
Sci Signal; 2020 Aug; 13(646):. PubMed ID: 32843541
[TBL] [Abstract][Full Text] [Related]
2. A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.
Zhang YY; Wu JW; Wang ZX
Sci Signal; 2011 Dec; 4(204):ra88. PubMed ID: 22375048
[TBL] [Abstract][Full Text] [Related]
3. A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding.
Shillingford S; Zhang L; Surovtseva Y; Dorry S; Lolis E; Bennett AM
J Biol Chem; 2022 Dec; 298(12):102617. PubMed ID: 36272649
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional docking in the MAPK p38α.
Goldsmith EJ
Sci Signal; 2011 Dec; 4(204):pe47. PubMed ID: 22375047
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.
Zhang YY; Mei ZQ; Wu JW; Wang ZX
J Biol Chem; 2008 Sep; 283(39):26591-601. PubMed ID: 18669639
[TBL] [Abstract][Full Text] [Related]
6. High molecular weight hyaluronic acid regulates MMP13 expression in chondrocytes via DUSP10/MKP5.
Furuta J; Ariyoshi W; Okinaga T; Takeuchi J; Mitsugi S; Tominaga K; Nishihara T
J Orthop Res; 2017 Feb; 35(2):331-339. PubMed ID: 27101204
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
Park H; Park SY; Nam SW; Ryu SE
J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
[TBL] [Abstract][Full Text] [Related]
8. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of the mitogen-activated protein kinase phosphatase-5 regulating the growth and invasion of a human prostate cancer cell line].
He HY; Fang WG; Zheng J; You JF; Heng WJ; Li Y
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1812-7. PubMed ID: 14642090
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase.
Jeong DG; Yoon TS; Kim JH; Shim MY; Jung SK; Son JH; Ryu SE; Kim SJ
J Mol Biol; 2006 Jul; 360(5):946-55. PubMed ID: 16806267
[TBL] [Abstract][Full Text] [Related]
11. A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury.
Qian F; Deng J; Cheng N; Welch EJ; Zhang Y; Malik AB; Flavell RA; Dong C; Ye RD
EMBO J; 2009 Oct; 28(19):2896-907. PubMed ID: 19696743
[TBL] [Abstract][Full Text] [Related]
12. Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5.
Shi H; Verma M; Zhang L; Dong C; Flavell RA; Bennett AM
J Clin Invest; 2013 May; 123(5):2064-77. PubMed ID: 23543058
[TBL] [Abstract][Full Text] [Related]
13. A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation.
Liu X; Zhang CS; Lu C; Lin SC; Wu JW; Wang ZX
Nat Commun; 2016 Mar; 7():10879. PubMed ID: 26988444
[TBL] [Abstract][Full Text] [Related]
14. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
He HY; Zheng J; Li Y; Heng WJ; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
[TBL] [Abstract][Full Text] [Related]
15. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases.
Theodosiou A; Smith A; Gillieron C; Arkinstall S; Ashworth A
Oncogene; 1999 Nov; 18(50):6981-8. PubMed ID: 10597297
[TBL] [Abstract][Full Text] [Related]
16. Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors.
Gannam ZTK; Jamali H; Kweon OS; Herrington J; Shillingford SR; Papini C; Gentzel E; Lolis E; Bennett AM; Ellman JA; Anderson KS
Eur J Med Chem; 2022 Dec; 243():114712. PubMed ID: 36116232
[TBL] [Abstract][Full Text] [Related]
17. MKP2 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells through a JNK-dependent pathway.
Li Z; Liu X; Tian F; Li J; Wang Q; Gu C
Clin Sci (Lond); 2018 Nov; 132(21):2339-2355. PubMed ID: 30322849
[TBL] [Abstract][Full Text] [Related]
18. An essential function for MKP5 in the formation of oxidized low density lipid-induced foam cells.
Luo LJ; Liu F; Wang XY; Dai TY; Dai YL; Dong C; Ge BX
Cell Signal; 2012 Oct; 24(10):1889-98. PubMed ID: 22683306
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
Nonn L; Peng L; Feldman D; Peehl DM
Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
